X-152651553-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_018558.4(GABRQ):c.929C>T(p.Thr310Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 112,725 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018558.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRQ | NM_018558.4 | c.929C>T | p.Thr310Ile | missense_variant | 8/9 | ENST00000598523.3 | NP_061028.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRQ | ENST00000598523.3 | c.929C>T | p.Thr310Ile | missense_variant | 8/9 | 1 | NM_018558.4 | ENSP00000469332.1 | ||
MAGEA3-DT | ENST00000671457.1 | n.130-11759G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 3AN: 112725Hom.: 0 Cov.: 24 AF XY: 0.0000287 AC XY: 1AN XY: 34857
GnomAD4 exome Cov.: 29
GnomAD4 genome AF: 0.0000266 AC: 3AN: 112725Hom.: 0 Cov.: 24 AF XY: 0.0000287 AC XY: 1AN XY: 34857
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.929C>T (p.T310I) alteration is located in exon 8 (coding exon 8) of the GABRQ gene. This alteration results from a C to T substitution at nucleotide position 929, causing the threonine (T) at amino acid position 310 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at